Surgical therapies, part III: Melanocyte transplants

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Melanocyte transplantation is currently the most effective treatment modality for patients who have stable depigmentation unresponsive to traditional medical therapies. Patient selection is extremely important since patients with active vitiligo or large areas of depigmentation will not respond well to this treatment method. This article discusses techniques available for harvesting and preparing donor tissue, preparing the depigmented recipient site, applying the melanocytes, and caring for the transplantation site postoperatively. Common complications and responses are also discussed. Many variations in the transplantation procedure exist, allowing practitioners to tailor the treatment to the facilities available and to individual patient needs. Melanocyte transplantation is becoming a more commonly utilized treatment option that is likely to increase in the future as medical therapies capable of halting the progression of vitiligo become available.

Original languageEnglish (US)
Pages (from-to)20-28
Number of pages9
JournalDermatologic Therapy
Volume14
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Melanocytes
Transplants
Transplantation
Vitiligo
Therapeutics
Patient Selection
Tissue Donors

Keywords

  • Depigmentation
  • Melanocyte transplant
  • Vitiligo

ASJC Scopus subject areas

  • Dermatology

Cite this

Surgical therapies, part III : Melanocyte transplants. / Leachman, Sancy.

In: Dermatologic Therapy, Vol. 14, No. 1, 2001, p. 20-28.

Research output: Contribution to journalArticle

@article{ade2ad2a11f84b96b023f7c650d44f10,
title = "Surgical therapies, part III: Melanocyte transplants",
abstract = "Melanocyte transplantation is currently the most effective treatment modality for patients who have stable depigmentation unresponsive to traditional medical therapies. Patient selection is extremely important since patients with active vitiligo or large areas of depigmentation will not respond well to this treatment method. This article discusses techniques available for harvesting and preparing donor tissue, preparing the depigmented recipient site, applying the melanocytes, and caring for the transplantation site postoperatively. Common complications and responses are also discussed. Many variations in the transplantation procedure exist, allowing practitioners to tailor the treatment to the facilities available and to individual patient needs. Melanocyte transplantation is becoming a more commonly utilized treatment option that is likely to increase in the future as medical therapies capable of halting the progression of vitiligo become available.",
keywords = "Depigmentation, Melanocyte transplant, Vitiligo",
author = "Sancy Leachman",
year = "2001",
doi = "10.1046/j.1529-8019.2001.014001020.x",
language = "English (US)",
volume = "14",
pages = "20--28",
journal = "Dermatologic Therapy",
issn = "1396-0296",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Surgical therapies, part III

T2 - Melanocyte transplants

AU - Leachman, Sancy

PY - 2001

Y1 - 2001

N2 - Melanocyte transplantation is currently the most effective treatment modality for patients who have stable depigmentation unresponsive to traditional medical therapies. Patient selection is extremely important since patients with active vitiligo or large areas of depigmentation will not respond well to this treatment method. This article discusses techniques available for harvesting and preparing donor tissue, preparing the depigmented recipient site, applying the melanocytes, and caring for the transplantation site postoperatively. Common complications and responses are also discussed. Many variations in the transplantation procedure exist, allowing practitioners to tailor the treatment to the facilities available and to individual patient needs. Melanocyte transplantation is becoming a more commonly utilized treatment option that is likely to increase in the future as medical therapies capable of halting the progression of vitiligo become available.

AB - Melanocyte transplantation is currently the most effective treatment modality for patients who have stable depigmentation unresponsive to traditional medical therapies. Patient selection is extremely important since patients with active vitiligo or large areas of depigmentation will not respond well to this treatment method. This article discusses techniques available for harvesting and preparing donor tissue, preparing the depigmented recipient site, applying the melanocytes, and caring for the transplantation site postoperatively. Common complications and responses are also discussed. Many variations in the transplantation procedure exist, allowing practitioners to tailor the treatment to the facilities available and to individual patient needs. Melanocyte transplantation is becoming a more commonly utilized treatment option that is likely to increase in the future as medical therapies capable of halting the progression of vitiligo become available.

KW - Depigmentation

KW - Melanocyte transplant

KW - Vitiligo

UR - http://www.scopus.com/inward/record.url?scp=0035079446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035079446&partnerID=8YFLogxK

U2 - 10.1046/j.1529-8019.2001.014001020.x

DO - 10.1046/j.1529-8019.2001.014001020.x

M3 - Article

AN - SCOPUS:0035079446

VL - 14

SP - 20

EP - 28

JO - Dermatologic Therapy

JF - Dermatologic Therapy

SN - 1396-0296

IS - 1

ER -